Vascular remodeling and media calcification increases arterial stiffness in chronic kidney disease

Clinical and Experimental Hypertension

Volumn 36, Issue 3, 2014, Pages 173-180

  Gauthier Bastien, Alexandra ^a   Ung, Roth Visal ^a   Larivière, Richard ^a   Mac Way, Fabrice ^a   Lebel, Marcel ^a   Agharazii, Mohsen ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Arterial stiffness; Chronic kidney disease; Pulse wave velocity; Vascular calcification; Vascular remodeling; Vitamin D

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CALCIUM; COLLAGEN TYPE 1; ELASTIN; OSTEOCALCIN; PHOSPHATE; VITAMIN D;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL STIFFNESS; ARTERY CALCIFICATION; ARTERY MEDIA; ARTERY WALL; ARTICLE; CELL DIFFERENTIATION; CHEMICAL PARAMETERS; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIETARY INTAKE; HEMODYNAMIC PARAMETERS; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; MALE; NEPHRECTOMY; NONHUMAN; OSTEOBLAST; PROTEIN EXPRESSION; PULSE PRESSURE; RAT; SMOOTH MUSCLE FIBER; TUNICA MEDIA; VITAMIN SUPPLEMENTATION; ANIMAL; AORTA; BLOOD; CALCINOSIS; CHRONIC KIDNEY FAILURE; COMPLICATION; DISEASE MODEL; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PULSE WAVE; RISK FACTOR; WISTAR RAT;

ANIMALS; AORTA; CALCINOSIS; DISEASE MODELS, ANIMAL; MALE; PULSE WAVE ANALYSIS; RATS, WISTAR; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; TUNICA MEDIA; VASCULAR STIFFNESS;

EID: 84898423276     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.3109/10641963.2013.804541     Document Type: Article

References (26)

1. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-305.
2. Blacher J, Asmar R, Djane S, et al. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 1999;33:1111-17.
3. Blacher J, Guerin AP, Pannier B, et al. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001;38:938-42.
4. Block GA, Hulbert-Shearon TE, Levin NW, et al. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998;31:607-17.
5. Goodman WG, Goldin J, Kuizon BD, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000;342:1478-83.
6. Kestenbaum B, Sampson JN, Rudser KD, et al. Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 2005;16:520-8.
7. Giachelli CM. The emerging role of phosphate in vascular calcification. Kidney Int 2009;75:890-7.
8. Steitz SA, Speer MY, Curinga G, et al. Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res 2001;89:1147-54.
9. Tyson KL, Reynolds JL, McNair R, et al. Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification. Arterioscler Thromb Vasc Biol 2003;23:489-94.
10. Speer MY, Yang HY, Brabb T, et al. Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries. Circ Res 2009;104:733-41.
11. Moe SM, Chen NX. Pathophysiology of vascular calcification in chronic kidney disease. Circ Res 2004;95:560-7.
12. Bouvet C, Moreau S, Blanchette J, et al. Sequential activation of matrix metalloproteinase 9 and transforming growth factor beta in arterial elastocalcinosis. Arterioscler Thromb Vasc Biol 2008;28: 856-62.
13. Chung AW, Yang HH, Kim JM, et al. Upregulation of matrix metalloproteinase-2 in the arterial vasculature contributes to stiffening and vasomotor dysfunction in patients with chronic kidney disease. Circulation 2009;120:792-801.
14. Lebel M, Rodrigue ME, Agharazii M, et al. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin. Am J Hypertens 2006;19: 1286-92.
15. Therrien FJ, Agharazii M, Lebel M, et al. Neutralization of tumor necrosis factor-alpha reduces renal fibrosis and hypertension in rats with renal failure. Am J Nephrol 2012;36:151-61.
16. Rancourt ME, Rodrigue ME, Agharazii M, et al. Role of oxidative stress in erythropoietin-induced hypertension in uremic rats. Am J Hypertens 2010;23:314-20.
17. Haffner D, Hocher B, Muller D, et al. Systemic cardiovascular disease in uremic rats induced by 1, 25(OH)2D3. J Hypertens 2005; 23:1067-75.
18. Price PA, June HH, Buckley JR, et al. Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D. Arterioscler Thromb Vasc Biol 2001;21:1610-16.
19. Qin X, Corriere MA, Matrisian LM, et al. Matrix metalloproteinase inhibition attenuates aortic calcification. Arterioscler Thromb Vasc Biol 2006;26:1510-16.
20. Lariviere R, Lebel M. Endothelin-1 in chronic renal failure and hypertension. Can J Physiol Pharmacol 2003;81:607-21.
21. Lariviere R, Moreau C, Rodrigue ME, et al. Thromboxane blockade reduces blood pressure and progression of renal failure independent of endothelin-1 in uremic rats. Prostaglandins Leukot Essent Fatty Acids 2004;71:103-9.
22. Lavoie P, Robitaille G, Agharazii M, et al. Neutralization of transforming growth factor-beta attenuates hypertension and prevents renal injury in uremic rats. J Hypertens 2005;23: 1895-903.
23. Savard S, Lavoie P, Villeneuve C, et al. eNOS gene delivery prevents hypertension and reduces renal failure and injury in rats with reduced renal mass. Nephrol Dial Transplant 2012;27: 2182-90.
24. Shobeiri N, Adams MA, Holden RM. Vascular calcification in animal models of CKD: a review. Am J Nephrol 2010;31: 471-81.
25. Bank AJ, Wang H, Holte JE, et al. Contribution of collagen, elastin, and smooth muscle to in vivo human brachial artery wall stress and elastic modulus. Circulation 1996;94:3263-70.
26. Shadwick RE. Mechanical design in arteries. J Exp Biol 1999;202: 3305-13.